Efficacy of different nutrients in age-related macular degeneration: A systematic review and network meta-analysis

REFERENCES

• Ge Y, Zhang A, Sun R, et al. Penetratin-modified lutein nanoemulsion in-situ gel for the treatment of age-related macular degeneration. Expert Opin Drug Deliv. 2020;17(4):603–619. doi:10.1080/17425247.2020.1735348.
   PubMed Web of Science ®Google Scholar
• Hollyfield JG, Bonilha VL, Rayborn ME, et al. Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat Med. 2008;14(2):194–198. doi:10.1038/nm1709.
   PubMed Web of Science ®Google Scholar
• Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Global Health. 2014;2(2):e106–e16. doi:10.1016/S2214-109X(13)70145-1.
   PubMed Web of Science ®Google Scholar
• Rozing MP, Durhuus JA, Krogh Nielsen M, et al. Age-related macular degeneration: a two-level model hypothesis. Prog Retin Eye Res. 2019;76:100825. doi:10.1016/j.preteyeres.2019.100825.
   PubMed Web of Science ®Google Scholar
• Brynskov T, Munch IC, Larsen TM, et al. Real-world 10-year experiences with intravitreal treatment with ranibizumab and aflibercept for neovascular age-related macular degeneration. Acta Ophthalmol. 2020;98(2):132–138. doi:10.1111/aos.14183.
   PubMed Web of Science ®Google Scholar
• Ma L, Yan SF, Huang YM, et al. Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration. Ophthalmology. 2012;119(11):2290–2297. doi:10.1016/j.ophtha.2012.06.014.
   PubMed Web of Science ®Google Scholar
• Age-Related Eye Disease Study Research G. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch Ophthalmol. 2001;119(10):1417–1436. AREDS report no. 8. doi:10.1001/archopht.119.10.1417.
   PubMedGoogle Scholar
• Age-Related Eye Disease Study 2 Research G, Chew EY, Clemons TE, SanGiovanni JP, et al. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3. JAMA Ophthalmol, 2014, 132(2):142–149. 10.1001/jamaophthalmol.2013.7376
   PubMed Web of Science ®Google Scholar
• Shaw PX, Stiles T, Douglas C, et al. Oxidative stress, innate immunity, and age-related macular degeneration. AIMS Mol Sci. 2016;3(2):196–221. doi:10.3934/molsci.2016.2.196.
   PubMed Web of Science ®Google Scholar
• Christen WG, Glynn RJ, Hennekens CH. Antioxidants and age-related eye disease. Current and future perspectives. Ann Epidemiol. 1996;6(1):60–66. doi:10.1016/1047-2797(95)00094-1.
   PubMed Web of Science ®Google Scholar
• Evans J. Antioxidant supplements to prevent or slow down the progression of AMD: a systematic review and meta-analysis. Eye (Lond). 2008;22(6):751–760. doi:10.1038/eye.2008.100.
   PubMed Web of Science ®Google Scholar
• Ma L, Dou H-L, Wu Y-Q, et al. Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis. Br J Nutr. 2011;107(3):350–359. doi:10.1017/S0007114511004260.
   PubMed Web of Science ®Google Scholar
• Feng L, Nie K, Jiang H, et al. Effects of lutein supplementation in age-related macular degeneration. PLoS One. 2019;14(12):e0227048. doi:10.1371/journal.pone.0227048.
   PubMed Web of Science ®Google Scholar
• Evans JR, Lawrenson JG. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane Database Syst Rev. 2017;7(7):CD000254. doi:10.1002/14651858.CD000254.
   Google Scholar
• Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–2012. doi:10.1001/jama.283.15.2008.
   PubMed Web of Science ®Google Scholar
• Jorgensen L, Paludan-Muller AS, Laursen DR, et al. Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials: overview of published comments and analysis of user practice in Cochrane and non-Cochrane reviews. Syst Rev. 2016;5(1):80. doi:10.1186/s13643-016-0259-8.
   PubMedGoogle Scholar
• Higgins JP, Jackson D, Barrett JK, et al. Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies. Res Synth Methods. 2012;3(2):98–110. doi:10.1002/jrsm.1044.
   PubMed Web of Science ®Google Scholar
• Hutton B, Salanti G, Caldwell DM, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777–784. doi:10.7326/M14-2385.
   PubMed Web of Science ®Google Scholar
• Chaimani A, Higgins JP, Mavridis D, et al. Graphical tools for network meta-analysis in STATA. PLoS One. 2013;8(10):e76654. doi:10.1371/journal.pone.0076654.
   PubMed Web of Science ®Google Scholar
• Salanti G, Higgins JP, Ades AE, et al. Evaluation of networks of randomized trials. Stat Methods Med Res. 2008;17(3):279–301. doi:10.1177/0962280207080643.
   PubMed Web of Science ®Google Scholar
• Salanti G. Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool. Res Synth Methods. 2012;3(2):80–97. doi:10.1002/jrsm.1037.
   PubMed Web of Science ®Google Scholar
• Salanti G, Ades AE, Ioannidis JP. Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol. 2011;64(2):163–171. doi:10.1016/j.jclinepi.2010.03.016.
   PubMed Web of Science ®Google Scholar
• Bartlett HE, Eperjesi F. Effect of lutein and antioxidant dietary supplementation on contrast sensitivity in age-related macular disease: a randomized controlled trial. Eur J Clin Nutr. 2007;61(9):1121–1127. doi:10.1038/sj.ejcn.1602626.
   PubMed Web of Science ®Google Scholar
• Beatty S, Chakravarthy U, Nolan JM, et al. Secondary outcomes in a clinical trial of carotenoids with coantioxidants versus placebo in early age-related macular degeneration. Ophthalmology. 2013;120(3):600–606. doi:10.1016/j.ophtha.2012.08.040.
   PubMed Web of Science ®Google Scholar
• Piermarocchi S, Saviano S, Parisi V, et al. Carotenoids in Age-related Maculopathy Italian Study (CARMIS): two-year results of a randomized study. Eur J Ophthalmol. 2012;22(2):216–225. doi:10.5301/ejo.5000069.
   PubMed Web of Science ®Google Scholar
• Murray IJ, Makridaki M, van der Veen RL, et al. Lutein supplementation over a one-year period in early AMD might have a mild beneficial effect on visual acuity: the CLEAR study. Invest Ophthalmol Vis Sci. 2013;54(3):1781–1788. doi:10.1167/iovs.12-10715.
   PubMed Web of Science ®Google Scholar
• Newsome DA, Swartz M, Leone NC, et al. Oral zinc in macular degeneration. Arch Ophthalmol. 1988;106(2):192–198. doi:10.1001/archopht.1988.01060130202026.
   PubMedGoogle Scholar
• Richer S, Stiles W, Statkute L, et al. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry - Journal of the American Optometric Association. 2004;75(4):216–229. doi:10.1016/S1529-1839(04)70049-4.
   PubMedGoogle Scholar
• Weigert G, Kaya S, Pemp B, et al. Effects of lutein supplementation on macular pigment optical density and visual acuity in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011;52(11):8174–8178. doi:10.1167/iovs.11-7522.
   PubMed Web of Science ®Google Scholar
• Teikari JM, Laatikainen L, Rapola JM, et al. Retinal vascular changes following supplementation with alpha-tocopherol or beta-carotene. Acta Ophthalmol Scand. 1998;76(1):68–73. doi:10.1034/j.1600-0420.1998.760112.x.
   PubMedGoogle Scholar
• Christen WG, Manson JE, Glynn RJ, et al. Beta carotene supplementation and age-related maculopathy in a randomized trial of US physicians. Arch Ophthalmol. 2007;125(3):333–339. doi:10.1001/archopht.125.3.333.
   PubMedGoogle Scholar
• Christen WG, Glynn RJ, Sesso HD, et al. Vitamins E and C and medical record-confirmed age-related macular degeneration in a randomized trial of male physicians. Ophthalmology. 2012;119(8):1642–1649. doi:10.1016/j.ophtha.2012.01.053.
   PubMed Web of Science ®Google Scholar
• Taylor HR, Tikellis G, Robman LD, et al. Vitamin E supplementation and macular degeneration: randomised controlled trial. BMJ. 2002;325(7354):11. doi:10.1136/bmj.325.7354.11.
   PubMedGoogle Scholar
• Christen WG, Glynn RJ, Chew EY, et al. Vitamin E and age-related macular degeneration in a randomized trial of women. Ophthalmology. 2010;117(6):1163–1168. doi:10.1016/j.ophtha.2009.10.043.
   PubMed Web of Science ®Google Scholar
• Finkel T. Signal transduction by reactive oxygen species. J Cell Biol. 2011;194(1):7–15. doi:10.1083/jcb.201102095.
   PubMed Web of Science ®Google Scholar
• Ichiishi E, Li XK, Iorio EL. Oxidative Stress and Diseases: clinical Trials and Approaches. Oxid Med Cell Longev. 2016;2016:3458276. doi:10.1155/2016/3458276.
   PubMed Web of Science ®Google Scholar
• Cross CE, Halliwell B, Borish ET, et al. Oxygen radicals and human disease. Ann Intern Med. 1987;107(4):526–545. doi:10.7326/0003-4819-107-4-526.
   PubMed Web of Science ®Google Scholar
• Black HS, Boehm F, Edge R, et al. The Benefits and Risks of Certain Dietary Carotenoids that Exhibit both Anti- and Pro-Oxidative Mechanisms-A Comprehensive Review. Antioxidants (Basel). 2020;9(3). doi:10.3390/antiox9030264.
   PubMedGoogle Scholar
• Bernstein PS, Li B, Vachali PP, et al. Lutein, zeaxanthin, and meso-zeaxanthin: the basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease. Prog Retin Eye Res. 2016;50:34–66. doi:10.1016/j.preteyeres.2015.10.003.
   PubMed Web of Science ®Google Scholar
• Gopinath B, Liew G, Tang D, et al. Consumption of eggs and the 15-year incidence of age-related macular degeneration. Clin Nutr. 2020;39(2):580–584. doi:10.1016/j.clnu.2019.03.009.
   PubMed Web of Science ®Google Scholar
• Buscemi S, Corleo D, Di Pace F, et al. The Effect of Lutein on Eye and Extra-Eye Health. Nutrients. 2018;10(9):1321. doi:10.3390/nu10091321.
   PubMed Web of Science ®Google Scholar
• Wu M, Feng Z, Deng Y, et al. Liquid antisolvent precipitation: an effective method for ocular targeting of lutein esters. Int J Nanomedicine. 2019;14:2667–2681. doi:10.2147/IJN.S194068.
   PubMed Web of Science ®Google Scholar
• Newsome DA. A randomized, prospective, placebo-controlled clinical trial of a novel zinc-monocysteine compound in age-related macular degeneration. Curr Eye Res. 2008;33(7):591–598. doi:10.1080/02713680802178437.
   PubMed Web of Science ®Google Scholar
• Zhang PC, Wu CR, Wang ZL, et al. Effect of lutein supplementation on visual function in nonproliferative diabetic retinopathy. Asia Pac J Clin Nutr. 2017;26(3):406–411. doi:10.6133/apjcn.032016.13.
   PubMed Web of Science ®Google Scholar
• Li SY, Fu ZJ, Ma H, et al. Effect of lutein on retinal neurons and oxidative stress in a model of acute retinal ischemia/reperfusion. Invest Ophthalmol Vis Sci. 2009;50(2):836–843. doi:10.1167/iovs.08-2310.
   PubMed Web of Science ®Google Scholar
• Age-Related Eye Disease Study Research G. Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: age-Related Eye Disease Study Report Number 3. Ophthalmology. 2000;107(12):2224–2232. doi:10.1016/s0161-6420(00)00409-7.
   PubMed Web of Science ®Google Scholar
• Bccpsg A-T. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994;330:1029–1035.
   PubMed Web of Science ®Google Scholar